{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:18:22Z","timestamp":1795025902856,"version":"4.10.2"},"reference-count":40,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031315","name":"AstraZeneca UK","doi-asserted-by":"publisher","award":["no award\/grand number - independent research grant"],"award-info":[{"award-number":["no award\/grand number - independent research grant"]}],"id":[{"id":"10.13039\/100031315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["no grant number"],"award-info":[{"award-number":["no grant number"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inhaled Antibiotic for Bronchiectasis and Cystic Fibrosis","award":["grant 115721"],"award-info":[{"award-number":["grant 115721"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,1,11]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Eosinophilic bronchiectasis is defined by a blood eosinophil count (BEC) \u2265300 cells\/\u00b5L, but blood eosinophils imperfectly reflect airway eosinophilic inflammation. Here, we investigated the relationship between eosinophilic airway inflammation, blood eosinophils and clinical severity in bronchiectasis and explored the phenotype associated with eosinophilic bronchiectasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sputum from 180 patients with stable CT-confirmed bronchiectasis was utilised to investigate airway levels of eosinophil proteins (eosinophil peroxidase (EPX), eosinophil derived-neurotoxin (EDN), eosinophil cationic protein (ECP), major basic protein (MBP) and Galectin-10 (Gal-10)) using a novel stable isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS\/MS) assay. To profile eosinophilic bronchiectasis, a nested analysis of patients with BEC &lt;150\u2009cells\/\u00b5L (n=52) and \u2265300\u2009cells\/\u00b5L (n=49) was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sputum concentrations of Gal-10, ECP and EDN were weakly but significantly associated with radiological severity, FEV\n                      <jats:sub>1<\/jats:sub>\n                      and sputum culture positivity for\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      . Airway eosinophil protein concentrations did not associate with exacerbation frequency. Total eosinophil protein concentration moderately correlated with BECs (r=0.33 95%\u2009CI 0.14 to 0.49, p=0.0007). Nested analysis revealed increased sputum PCR-positivity for\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      (26.7% vs 7.7%, p=0.033) and an increased frequency of patients showing signs of\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      sensitisation (defined as\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      -specific IgE titres &gt;0.35\u2009kUA\/L, 24.5% vs 3.8%) in eosinophilic bronchiectasis. Sputum inflammatory biomarkers and clinical parameters did not differ between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      LC-MS\/MS can detect eosinophilic inflammation within bronchiectasis sputum. Weak associations between elevated airway eosinophil proteins, bronchiectasis severity and\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      infection were observed. Direct measurement of eosinophilic airway inflammation provides additional information in addition to BECs. Eosinophilic bronchiectasis associated with\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      infection and\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      sensitisation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2025-223305","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:25:29Z","timestamp":1771050329000},"page":"642-653","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE study"],"prefix":"10.1136","volume":"81","author":[{"given":"Jennifer","family":"Pollock","sequence":"first","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T J","family":"Huang","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morven","family":"Shuttleworth","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete B","family":"Long","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollian","family":"Richardson","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Alferes de Lima","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kuzmanova","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Clarke","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-3398","authenticated-orcid":false,"given":"Michal","family":"Shteinberg","sequence":"additional","affiliation":[{"name":"Pulmonology Institute and CF center, Carmel Medical Center, Haifa, Israel"},{"name":"The B. Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Milan, Italy"},{"name":"IRCCS Humanitas Research Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Haworth","sequence":"additional","affiliation":[{"name":"Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0417-7607","authenticated-orcid":false,"given":"Sanjay Haresh","family":"Chotirmall","sequence":"additional","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"},{"name":"Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Polverino","sequence":"additional","affiliation":[{"name":"Pneumology Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C","family":"Goeminne","sequence":"additional","affiliation":[{"name":"Respiratory Disease, AZ Nikolaas, Sint-Niklaas, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Loebinger","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital, London, UK"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Lorent","sequence":"additional","affiliation":[{"name":"Department of Pneumology, University Hospital Leuven, Leuven, Belgium"},{"name":"BREATHE laboratory, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-4968","authenticated-orcid":false,"given":"Felix C","family":"Ringshausen","sequence":"additional","affiliation":[{"name":"German Centre for Lung Research, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[{"name":"Instituto Cl\u00ednico de Respiratorio, IDIBAPS, Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Rodriguez-Suarez","sequence":"additional","affiliation":[{"name":"Translational Science and Experimental Medicine, Early Respiratory and Immunology, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McCrae","sequence":"additional","affiliation":[{"name":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-6060","authenticated-orcid":false,"given":"Amelia","family":"Shoemark","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-7868","authenticated-orcid":false,"given":"James D","family":"Chalmers","sequence":"additional","affiliation":[{"name":"University of Dundee, Dundee, UK"},{"name":"Radcliffe Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"2026061502201455000_81.7.642.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31767-7"},{"key":"2026061502201455000_81.7.642.2","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070772","article-title":"T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis","volume":"9","author":"Oriano","year":"2021","journal-title":"Biomedicines"},{"key":"2026061502201455000_81.7.642.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1889OC"},{"key":"2026061502201455000_81.7.642.4","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1 , et al . The U-shaped relationship between eosinophil count and bronchiectasis severity: the effect of inhaled corticosteroids. Chest 2023;164. doi:10.1016\/j.chest.2023.04.029","DOI":"10.1016\/j.chest.2023.04.029"},{"key":"2026061502201455000_81.7.642.5","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.3390\/ijerph18168431","article-title":"Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity","volume":"18","author":"Wang","year":"2021","journal-title":"IJERPH"},{"key":"2026061502201455000_81.7.642.6","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201506-333OC"},{"key":"2026061502201455000_81.7.642.7","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2000.d01-64.x"},{"key":"2026061502201455000_81.7.642.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.09.023"},{"key":"2026061502201455000_81.7.642.9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.201807-1355OC","article-title":"Distinct \u201cImmunoallertypes\u201d of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis Bronchiectasis","volume":"199","author":"Mac Aog\u00e1in","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026061502201455000_81.7.642.10","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S196200"},{"key":"2026061502201455000_81.7.642.11","doi-asserted-by":"crossref","first-page":"106491","DOI":"10.1016\/j.rmed.2021.106491","article-title":"Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study","volume":"185","author":"Crimi","year":"2021","journal-title":"Respir Med"},{"key":"2026061502201455000_81.7.642.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106127"},{"key":"2026061502201455000_81.7.642.13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01333-2019","article-title":"Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series","volume":"55","author":"Rademacher","year":"2020","journal-title":"Eur Respir J"},{"key":"2026061502201455000_81.7.642.14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00453-2020","article-title":"Blood eosinophils predict inhaled fluticasone response in bronchiectasis","volume":"56","author":"Aliberti","year":"2020","journal-title":"Eur Respir J"},{"key":"2026061502201455000_81.7.642.15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur Respir J"},{"key":"2026061502201455000_81.7.642.16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1164\/rccm.201912-2384PP","article-title":"Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease","volume":"202","author":"Singh","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026061502201455000_81.7.642.17","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00081-2015","article-title":"The EMBARC European Bronchiectasis Registry: protocol for an international observational study","volume":"2","author":"Chalmers","year":"2016","journal-title":"ERJ Open Res"},{"key":"2026061502201455000_81.7.642.18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026061502201455000_81.7.642.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC"},{"key":"2026061502201455000_81.7.642.20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"key":"2026061502201455000_81.7.642.21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00766-2018","article-title":"Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study","volume":"52","author":"Mac Aog\u00e1in","year":"2018","journal-title":"Eur Respir J"},{"key":"2026061502201455000_81.7.642.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1027OC"},{"key":"2026061502201455000_81.7.642.23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026061502201455000_81.7.642.24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02536-2017","article-title":"Associations between blood eosinophils and decline in lung function among adults with and without asthma","volume":"51","author":"Hancox","year":"2018","journal-title":"Eur Respir J"},{"key":"2026061502201455000_81.7.642.25","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00320-2020","article-title":"Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts","volume":"6","author":"Mogensen","year":"2020","journal-title":"ERJ Open Res"},{"key":"2026061502201455000_81.7.642.26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jlb.52.6.611","article-title":"Eosinophil granule proteins in peripheral blood granulocytes","volume":"52","author":"Abu-Ghazaleh","year":"1992","journal-title":"J Leukoc Biol"},{"key":"2026061502201455000_81.7.642.27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R113.546218"},{"key":"2026061502201455000_81.7.642.28","first-page":"2125","article-title":"Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review","volume":"10","author":"Requena","year":"2022","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"key":"2026061502201455000_81.7.642.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.02.040"},{"key":"2026061502201455000_81.7.642.30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"2026061502201455000_81.7.642.31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.anai.2016.08.010","article-title":"Variability of blood eosinophil count as an asthma biomarker","volume":"117","author":"Mathur","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026061502201455000_81.7.642.32","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202010-1249OC"},{"key":"2026061502201455000_81.7.642.33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"The Lancet"},{"key":"2026061502201455000_81.7.642.34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1515\/cclm-2016-0716","article-title":"Within-day biological variation and hour-to-hour reference change values for hematological parameters","volume":"55","author":"Hilderink","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2026061502201455000_81.7.642.35","doi-asserted-by":"crossref","DOI":"10.4102\/ajlm.v4i1.208","article-title":"Prolonged storage-induced changes in haematology parameters referred for testing","volume":"4","author":"Schapkaitz","year":"2015","journal-title":"Afr J Lab Med"},{"key":"2026061502201455000_81.7.642.36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1239151","article-title":"Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease","volume":"14","author":"Chalmers","year":"2023","journal-title":"Front Immunol"},{"key":"2026061502201455000_81.7.642.37","doi-asserted-by":"crossref","unstructured":"Chalmers JD , Metersky ML , Teper A , et al . Dipeptidyl peptidase-1 inhibition in bronchiectasis with eosinophilic endotype in the willow trial. ERS International Congress 2023 abstracts; September 9, 2023:A2835. doi:10.1183\/13993003.congress-2023.PA2835","DOI":"10.1183\/13993003.congress-2023.PA2835"},{"key":"2026061502201455000_81.7.642.38","doi-asserted-by":"publisher","DOI":"10.1016\/J.IM-MUNI.2022.04.001"},{"key":"2026061502201455000_81.7.642.39","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00274","article-title":"Biofilm-Induced Type 2 Innate Immunity in a Cystic Fibrosis Model of Pseudomonas aeruginosa","volume":"7","author":"Bielen","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2026061502201455000_81.7.642.40","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-011-0217-4"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-223305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:22:32Z","timestamp":1781515352000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-223305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,15]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/thorax-2025-223305"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-223305","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}